Description
Detailed description is being prepared by our clinical team.
Clinical Trials
NCT07563907
Not Applicable
Not yet recruiting
Total Neoadjuvant Therapy With Additional Consolidation Chemotherapy Followed by Local Excision Versus Total Neoadjuvant Therapy Followed by Local Excision at Stage I Rectal Cancer
South Korea
NCT07651007
Phase 2
Not yet recruiting
Short-course RT Followed by NALIRIFOX Plus Pucotenlimab as Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer With MSS/pMMR